In addition, liraglutide treatment reduced the hyperglycemia-enhanced expression of Tgf-β, which is associated with vascular complications in patients with diabetes [48, 49]; this change is consistent with the reduction in cell density. This evidence concerns the gene TGFB1 and diabetes mellitus.